Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers
Background: Calcific aortic valve disease (CAVD) is a rapidly growing global health problem with an estimated 12.6 million cases globally in 2017 and a 112% increase of deaths since 1990 due to aging and population growth. CAVD may develop into aortic stenosis (AS) by progressive narrowing of the ao...
Main Authors: | Beau Olivier van Driel, Maike Schuldt, Sila Algül, Evgeni Levin, Ahmet Güclü, Tjeerd Germans, Albert C. van Rossum, Jiayi Pei, Magdalena Harakalova, Annette Baas, Judith J. M. Jans, Jolanda van der Velden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/7/3569 |
Similar Items
-
Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
by: Maike Schuldt, et al.
Published: (2021-10-01) -
The effect of inhibition of the Na<sup>+</sup>/H<sup>+</sup> exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
by: van der Velden Jolanda, et al.
Published: (2011-02-01) -
Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis
by: Mark Jansen, et al.
Published: (2022-10-01) -
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
by: Götte Marco, et al.
Published: (2009-01-01) -
Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder Variants
by: Mark Jansen, et al.
Published: (2023-02-01)